US: AstraZeneca to acquire TeneoTwo for US$1.27bn
UK/Swedish global bio-pharmaceutical company, AstraZeneca, is strengthening its haematological cancer pipeline with the acquisition of US-based TeneoTwo and its Phase I clinical-stage T-cell engager,...
Italy: Dedalus to acquire Lutech’s healthcare software division
Dedalus Group, the leading healthcare and diagnostic software provider in Europe, has finalized an agreement to acquire the healthcare software division of Lutech Group,...
The Netherlands: Affidea maintains growth trajectory with acquisitions in three countries
Europe's largest provider of advanced imaging, outpatient and cancer treatment services, Affidea Group, continues to expand its footprint across Europe with acquisitions of seven...
The Netherlands: Biosynth Carbosynth expands peptide offering with Pepscan
Switzerland-based Biosynth Carbosynth, a supplier of critical products and services to the life sciences industry, has acquired Pepscan in the Netherlands, a provider of...
Denmark: Ambea’s Altiden strengthens social care position in Denmark
Nasdaq Stockholm-listed Ambea, the market leading care provider in Sweden, Norway and Denmark respectively, through its Altiden group member, has acquired two Danish social...
Italy: TPG Cap to acquire majority stake in DOC Generici from ICG and...
TPG Capital, the private equity platform of global alternative asset management firm TPG, has signed a definitive agreement to acquire a majority interest in...
Denmark: ProductLife Group expands service offering with Pharma IT acquisition
ProductLife Group (PLG), a global provider of specialized services for the pharmaceutical, medtech and biotech industries, has acquired Pharma IT, a life sciences consulting...
Finland: Triton acquires majority stake in Esperi Care
European investor, Triton through its Triton Smaller Mid Cap Fund II, has acquired a majority share in Esperi Care, a residential care provider in...
Spain: Cofinimmo reiterates commitment in Spain with new nursing home for Murcia
Belgian real estate investment trust, Cofinimmo, is building a new 150 bed nursing and care home in Murcia on a plot of land acquired...
France: Ipsen expands oncology assets through acquisition of Epizyme
Euronext Paris listed Ipsen, a global, mid-sized biopharmaceutical company focused on oncology, rare disease and neuroscience, is acquiring Nasdaq listed Epizyme, a US-based fully...
©2023 All rights reserved LaingBuisson 
